tiprankstipranks
Trending News
More News >
Immunotech Biopharm Ltd (HK:6978)
:6978
Hong Kong Market

Immunotech Biopharm Ltd (6978) Income Statement

Compare
1 Followers

Immunotech Biopharm Ltd Income Statement

Last quarter (Q2 2025), Immunotech Biopharm Ltd's total revenue was ¥0.00, a decrease of ― from the same quarter last year. In Q2, Immunotech Biopharm Ltd's net income was ¥-129.10M. See Immunotech Biopharm Ltd’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
¥ 0.00¥ 0.00¥ 0.00¥ 0.00¥ 0.00
Gross Profit
¥ 0.00¥ 0.00¥ 0.00¥ 0.00¥ 0.00
Operating Expenses
¥ 198.78M¥ 230.55M¥ 273.93M¥ 344.86M¥ 347.25M
Depreciation and Amortization
¥ 52.22M¥ 52.22M¥ 43.11M¥ 21.00M¥ 13.78M
EBITDA
¥ -148.68M¥ -178.83M¥ -231.11M¥ -324.33M¥ -333.99M
Operating Income
¥ -198.78M¥ -230.55M¥ -273.93M¥ -344.86M¥ -347.25M
Other Income/Expenses
¥ 12.36M¥ -104.93M¥ -47.16M¥ -9.75M¥ -91.88M
Pretax Income
¥ -186.42M¥ -335.48M¥ -321.10M¥ -354.62M¥ -439.13M
Net Income
¥ -186.91M¥ -334.82M¥ -318.11M¥ -354.22M¥ -439.05M
Per Share Metrics
Basic EPS
¥ -0.36¥ -0.65¥ -0.62¥ -0.69¥ -0.99
Diluted EPS
¥ -0.36¥ -0.65¥ -0.62¥ -0.69¥ -0.99
Weighted Average Shares Outstanding
514.58M 514.58M 514.58M 514.58M 443.81M
Weighted Average Shares Outstanding (Diluted)
514.58M 514.58M 514.58M 514.58M 443.81M
Currency in CNY

Immunotech Biopharm Ltd Earnings and Revenue History